Using ecg and ai to detect blood sugar changes in type 1 diabetes
Part of Hormones & metabolism clinical trials.
This study uses a small device to record your heart's electrical activity (ECG) and artificial intelligence to see if it can track your blood sugar levels without finger pricks. If it works, it could make managing type 1 diabetes easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You should not have an acute illness or be undergoing active medical investigations.
- You should not have a fear of needles.
- You should not have conditions that affect your metabolism (like thyroid problems, Cushing's syndrome, or chronic inflammatory diseases).
- You should not be actively trying to lose weight.
- You must be able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new wearable sensor to see if it can help people with type 1 diabetes better track their blood sugar levels. It might lead to easier and more accurate glucose monitoring.
This study uses artificial intelligence to analyze glucose monitor data from people with type 1 diabetes. The goal is to find patterns that could improve care and treatment.
This study tests a wearable device that may measure blood sugar without needles. It could help people manage their diet and health more easily.
If you have type 1 diabetes, this study tests a personalized tool that gives you advice on managing your blood sugar during and after exercise. If you are a healthy volunteer, you might join to provide a comparison group. The study involves moderate walking sessions while wearing a continuous glucose monitor (CGM) and using a special app.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
Hear when a new Metabolic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.